Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000089.xml
Ultraschall Med 2013; 34(5): 435-440
DOI: 10.1055/s-0033-1335685
DOI: 10.1055/s-0033-1335685
Quality Assurance
Empfehlungen der DEGUM zur Durchführung von Amniozentese und Chorionzottenbiopsie
DEGUM Guidelines for Amniocentesis and Chorionic Villus SamplingFurther Information
Publication History
14 September 2012
30 April 2013
Publication Date:
14 October 2013 (online)

-
Literatur
- 1 Merz E, Eichhorn KH, Kaisenberg C et al. Aktualisierte Qualitätsanforderungen an die weiterführende differenzierte Ultraschalluntersuchung in der pränatalen Diagnostik (= DEGUM-Stufe II) im Zeitraum von 18 + 0 bis 21 + 6 Schwangerschaftswochen. Ultraschall in Med 2012; 33: 593-596
- 2 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), Arbeitsgemeinschaft für Ultraschalldiagnostik (ARGUS), Deutsche Gesellschaft für Ultraschall in der Medizin – Sektion Gynäkologie (DEGUM-Stufe III). Ultraschalluntersuchung in der Frühschwangerschaft. AWMF–Leitlinien-Register Nr. 015/032, 12.10.2010
- 3 Chaoui R, Heling KS, Mielke G et al. Qualitätsanforderungen der DEGUM zur Durchführung der fetalen Echokardiografie. Ultraschall in Med 2008; 29: 197-200
- 4 Merz E, Meinel K, Bald R et al. DEGUM- Stufe- III Empfehlungen zur „weiterführenden“ sonographischen Untersuchung (= DEGUM Stufe II) im Zeitraum 11 – 14 Schwangerschaftswochen. Ultraschall in Med 2004; 25: 218-220
- 5 Tabor A, Alfirevic Z. Update on Procedure-Related Risks for Prenatal Diagnosis Techniques. Fetal Diagn Ther 2010; 27: 1-7
- 6 Canadian Early and Mid-trimester Amniocentesis Trial (CEMAT) Group. Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. Lancet 1998; 351: 242-247
- 7 Nicolaides K, Brizot Mde L, Patel F et al. Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10–13 weeks’ gestation. Lancet 1994; 344: 435-439
- 8 Philip J, Silver RK, Wilson RD et al. Late first-trimester invasive prenatal diagnosis: results of an international randomized trial. Obstet Gynecol 2004; 103: 1164-1173
- 9 Sundberg K, Bang J, Smidt-Jensen S et al. Randomised study of the risk of fetal loss related to early amniocentesis versus chorionic villus sampling. Lancet 1997; 350: 697-703
- 10 Cederholm M, Haglund B, Axelsson O. Infant morbidity following amniocentesis and chorionic villus sampling for prenatal karyotyping. BJOG 2005; 112: 394-402
- 11 Firth HV, Boyd PA, Chamberlain P et al. Severe limb abnormalities after chorion villus sampling at 56-66 days’ gestation. Lancet 1991; 337: 762-763
- 12 Mastroiacovo P, Tozzi AE, Agosti S et al. Transverse limb reduction defects after chorion villus sampling: a retrospective cohort study. GIDEF--Gruppo Italiano Diagnosi Embrio-Fetali. Prenat Diagn 1993; 13: 1051-1056
- 13 WHO/PAHO Consultation of CVS. Evaluation of Chorion Villus Sampling Safety. Prenat Diagn 1999; 19: 97-99
- 14 Royal College of Obstetricians and Gynaecologists. Amniocentesis and Chorion Villous Sampling, Green-top Guideline No 8. 2010
- 15 Gosden C, Tabor A, Leck I et al. Amniocentesis and chorionic villus sampling. In: Wald N, Leck I, (eds.): Antenatal and Neonatal Screening. London: Oxford University Press; 2000: 470-517
- 16 Fryburg JS, Dimaio MS, Yang-Feng TL et al. Follow-up of pregnancies complicated by placental mosaicism diagnosed by chorionic villus sampling. Prenatal Diagnosis 1993; 13: 481-494
- 17 Tyson RW. Chromosomal abnormalities in stillbirth and neonatal death. In: Dimmick JE and Kalousek DK (eds.): Developmental pathology of the embryo and fetus. Philadelphia: Lippincott; 1992: 103-109
- 18 Wilkins-Haug L, Quade B, Morton CC. Confined placental mosaicism as a risk factor among newborns with fetal growth restriction. Prenat Diagn 2006; 26: 28-32
- 19 Amor DJ, Neo WT, Waters E et al. Health and developmental outcome of children following prenatal diagnosis of confined placental mosaicism. Prenat Diagn 2006; 26: 443-448
- 20 Miura K, Yoshiura K, Miura S et al. Clinical outcome of infants with confined placental mosaicism and intrauterine growth restriction of unknown cause. Am J Med Genet A 2006; 17: 1827-1833
- 21 Mandelbrot L, Jasseron C, Ekoukou D et al. Amniocentesis and mother-to-child human immunodeficiency virus transmission in the Agence Nationale de Recherches sur le SIDA et les Hépatites Virales French Perinatal Cohort. Am J Obstet Gynecol 2009; 200: 160.e1-160.e9
- 22 Merz E. Invasive pränatale Diagnostik. In: Merz E, (Hrsg.): Sonographische Diagnostik in Gynäkologie und Geburtshilfe. Band 2: Geburtshilfe. Thieme; 2002: 532-560
- 23 Brambati B, Oldrini A, Lanzani A et al. Transabdominal versus transcervical chorionic villus sampling: a randomized trial. Hum Reprod 1988; 3: 811-813
- 24 Alfirevic Z, Sundberg K, Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev 2003; CD003252. 3
- 25 Smidt-Jensen S. Transabdominal chorionic villus sampling. Method, safety and accuracy. Dan Med Bull 1998; 45: 402-411
- 26 Yukobowich E, Anteby EY, Cohen SM et al. Risk of Fetal Loss in Twin Pregnancies Undergoing Second Trimester Amniocentesis. Obstet Gynecol 2001; 98: 231-234
- 27 Agarwal K, Alfirevic Z. Pregnancy Loss after Chorionic Villus Sampling and Genetic Amniocentesis in Twin Pregnancies- a Systematic Review. Ultrasound Obstet Gynecol [published online]: 2012;
- 28 Cahill AG, Macones GA, Stamilio DM et al. Pregnancy loss rate after mid-trimester amniocentesis in twin pregnancies. Am J Obstet Gynecol 2009; 200: 257.e1-257.e6
- 29 Vayssière C, Benoist G, Blondel B et al. Twin pregnancies:guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF). Eur J Obstet Gynecol 2011; 156: 12-17
- 30 Seeds JW. Diagnostic mid trimester amniocentesis: How safe?. Am J Obst Gynecol 2004; 191: 608e16
- 31 Devlieger R, Millar LK, Bryant-Greenwood G et al. Fetal membrane healing after spontaneous and iatrogenic membrane rupture: A review of current evidence. Am J Obstet Gynecol 2006; 195: 1512-1520
- 32 Borgida AF, Mills AA, Feldman DM et al. Outcome of pregnancies complicated by ruptured membranes after genetic amniocentesis. Am J Obstet Gynecol 2000; 183: 937-939
- 33 Hösli I, Walter-Göbel I, Tercanli S et al. Spontaneous fetal loss rates in a non-selected population. Am J Med Gene 2001; 100: 106-109
- 34 Mujezinovic F, Alfirevic Z. Procedure-Related Complications of Amniocentesis and Chorionic Villous Sampling. A Systematic Review. Obstet Gynecol 2007; 110: 687-94
- 35 Midtrimester amniocentesis for prenatal diagnosis. Safety and accuracy. JAMA 1976; 236: 1471-1476
- 36 An assessment of the hazards of amniocentesis. Report to the Medical Research Council by their Working Party on Amniocentesis. Br J Obstet Gynaecol 1978; 85: 1-41
- 37 Simpson NE et al. Prenatal diagnosis of genetic disease in Canada: report of a collaborative study. Can Med Assoc J 1976; 115: 739-748
- 38 Tabor A, Philip J, Madsen M et al. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986; 1: 1287-1293
- 39 Odibo AO, Gray DL, Dicke JM et al. Revisiting the Fetal Loss Rate After Second-Trimester Genetic Amniocentesis A Single Center’s 16-Year Experience. Obstet Gynecol 2008; 111: 589-595
- 40 Eddleman KA, Malone FD, Sullivan L et al. Pregnancy Loss Rates After Midtrimester Amniocentesis. Obstet Gynecol 2006; 108: 1067-1072
- 41 Caughey AB, Hopkins LM, Norton ME. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol 2006; 108: 612-616
- 42 Kozlowski P, Knippel P, Stressig R. Individual Risk of Fetal Loss Following Routine Second Trimester Amniocentesis: A Controlled Study of 20460 Cases. Ultraschall in Med 2008; 29: 165-172
- 43 Tabor A, Vestergaard CHF, Lidegaard Ø. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study. Ultrasound Obstet Gynecol 2009; 34: 19-24
- 44 Towner D, Currier RJ, Lorey FW et al. Miscarriage risk from amniocentesis performed for abnormal maternal serum screening. Am J Obstet Gynecol 2007; 196: 608.e 1-5
- 45 Muller F, Thibaud D, Poloce F et al. Risk of amniocentesis in women screened positive for Down syndrome with second trimester maternal serum markers. Prenat Diagn 2002; 22: 1036-1039
- 46 Enzensberger C, Pulvermacher C, Degenhardt J et al. Fetal Loss Rate and Associated Risk Factors After Amniocentesis, Chorionic Villus Sampling and Fetal Blood Sampling. Ultraschall in Med 2012; 33 (7) E75-E79
- 47 American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol 2007; 110: 1459-1467
- 48 Bombard AT, Powers JF, Carter S et al. Procedure-related fetal losses in transplacental versus nontransplacental genetic amniocentesis. Am J Obstet Gynecol 1995; 172: 868-872
- 49 Marthin T, Liedgren S, Hammar M. Transplacental needle passage and other risk-factors associated with second trimester amniocentesis. Acta Obstet Gynecol Scand 1997; 76: 728-732
- 50 Hill LM, Platt LD, Kellogg B. Rh sensitization after genetic amniocentesis. Obstet Gynecol 1980; 56: 459-461
- 51 Johnson JM, Wilson RD, Singer J et al. Technical factors in early amniocentesis predict adverse outcome. Results of the Canadian Early (EA) versus Mid-trimester (MA) Amniocentesis Trial. Prenat Diagn 1999; 19: 732-738
- 52 Alfirevic Z. Who should be allowed to perform amniocentesis and chorionic villus sampling?. Ultrasound Obstet Gynecol 2009; 34: 12-13
- 53 Leschot NJ, Verjaal M, Treffers PE. Risks of midtrimester amniocentesis: assessment in 3,000 pregnancies. Br J Obstet Gynaecol 1985; 92: 804-807
- 54 Wijnberger LDE, van der Schouw YT, Christiaens GCML. Learning in medicine: chorionic villus sampling. Prenat Diagn 2000; 20: 241-246
- 55 Nizard J, Duyme M, Ville Y. Teaching ultrasound-guided invasive procedures in fetal medicine: learning curves with and without an electronic guidance system. Ultrasound Obstet Gynecol 2002; 19: 274-277